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Summary.-The effect of the growth of two syngeneic transplanted sarcomata of
widely differing biological properties on the number of monocytes in the blood
of rats was measured (1) by binding of a specific antimacrophage serum to leuco-
cytes, and (2) by sedimenting in a density gradient rosettes between mononuclear
cells and antibody-coated sheep red cells under conditions in which B-cells are not
brought down. For the 4 syngeneic sarcomata studied there was a progressive
increase in the number of monocytes with tumour growth and the values returned
to normal a few days after their surgical removal. The extent of monocytosis was
related to the immunogenicity of the tumour and was most pronounced for the
HSBPA sarcoma, which is highly immunogenic, has a low rate of spontaneous
metastasis and contains many macrophages, and least for the MC-3 sarcoma which
is essentially non-immunogenic, invariably gives rise to distant metastases and
contains only about 8% macrophages. The growth of sarcomata had previously
been found to reduce the number of monocytes which enter inflammatory lesions,
both non-specific and due to a delayed hypersensitivity reaction. This " anti-
inflammatory" action of sarcomata which is related to their immunogenicity
cannot be ascribed to the preferential uptake of monocytes by the tumours and it
is concluded that the monocytes in the blood of tumour-bearers, though increased
in number, are modified so that they do not enter sites of inflammation.
IN a previous study (Eccles and
Alexander, 1974a) syngeneic transplanted
sarcomata were found to vary widely
in the extent to which they reduced the
capacity of rats to mount non-specific
inflammatory reactions, as well as delayed
hypersensitivity responses to antigens
unrelated to the tumour. The former
was measured by counting the number
of macrophages recoverable from the
peritoneal cavity 4 days after stimulation
with oyster glycogen (in normal rats this
produced an increase from 2 to 14 x 106
macrophages per rat). The effect on
delayed hypersensitivity was assessed by
measuring the degree of swelling of
foot pads following injection of either
sheep red blood cells (SRBC) or PPD
into rats which had been previously
sensitized with SRBC or BCGrespectively.
A number of tests showed that this
" anti-inflammatory " effect of tumour
growth was due to a failure of monocytes
to extravasate into the sites of inflamma-
tion or antigen challenge and was not
caused by a reduction in the number
of allergized lymphocytes. The intensity
of both types of reaction decreased pro-
gressively as the tumours grew and re-
turned to normal within 6 days oftumour
excision. For a given size of tumour,
there was a correlation between the
degree of suppression and the macro-
phage content of the tumour (which for
the different sarcomata studied ranged
from 3 to 58% of the total cells). SinceMONOCYTOSIS DURING GROWTH OF SARCOMATA
Evans (1972) had shown that the macro-
phages in the tumour are of host origin,
and as they do not divide in situ they
must all be derived from blood mono-
cytes. This suggested that the failure
of monocytes to reach sites of inflamma-
tion in tumour-bearing rats might be
caused by sequestration of the circulating
monocytes within the tumour. A corol-
lary of this hypothesis is that the number
of circulating monocytes in the blood
should fall in parallel with the observed
"anti-inflammatory " effects.
Monocytes, unlike their mature coun-
terparts macrophages-cannot always be
reliably identified using morphological
criteria alone, and the immature forms
which tended to appear in the blood
of tumour-bearing animals were particu-
larly difficult to distinguish from other
early cell types. For this reason two
alternative methods, which depend on
functional properties were devised to
identify blood monocytes:
(1) Membrane fluorescence using a
specific rabbit anti-rat macrophage serum
(RAMS). (2) Separation by density sedi-
mentation of rosettes formed between
monocytes and antibody-coated sheep red
cells (EA rosettes). These tests showed
that growth of sarcomata induced a
marked monocytosis and the " anti-
inflammatory" action cannot, therefore,
be ascribed to the preferential attraction
of monocytes to the tumour leading to
a depletion of monocytes elsewhere. Con-
sequently, the mechanism whereby mono-
cytes are able to enter tumours but have
a reduced capacity to enter sites of
inflammation or antigen challenge, has
yet to be explained.
MATERIALS AND METHODS
Transplantation, of tumours.-The chemic-
ally-induced sarcomata were transplanted
by mechanically prepared cell suspenvions
into the legs of syngeneic male 10-week-old
" hooded " rats. The average macrophage
contents of the HSBPA, HSN, MC-1 and
MC-3 sarcomata were respectively 54%O, 40%, 38% and 8%. Their biological pro-
perties have been described previously
(Eccles and Alexander, 1974a, b).
Preparation of blood mononuclear cells.-
Heparinized blood was obtained from the
jugular vein of anaesthetized animals and
a total white blood cell count was made.
The whole blood was then layered on to
an equal volume of Ficoll-Triosil (density
1 077 gm/ml) at room temperature. The
tubes were spun at 200 g for 10 min, then
600 g for 15 min. The upper cell layer
containing mononuclear cells was taken,
washed twice with Medium 199, and the
cells counted and expressed per ml of whole
blood. The monocyte content of this frac-
tion was then assayed by the following
methods and expressed as number ofcells/ml
of blood.
Production of anti-macrophage serum
(RAMS).-Rat peritoneal cells were harvest-
ed 3 days after the i.p. injection of 4 mg
oyster glycogen and plated into 3-cm Petri
dishes. The cells were incubated overnight
in serum-free medium at 37°C, which allowed
strong adherence of the mononuclear phago-
cytes to the plastic. The non-adherent
cells were washed off and discarded, and
the adherent cells removed with a rubber
policeman, and used for immunization of
a rabbit. The first immunization consisted
of 107 macrophages emulsified with complete
Freund's adjuvant injected s.c., and 106
macrophages injected i.v. Three subsequent
immunizations consisting of 107 macrophages
in incomplete Freund's adjuvant injected
s.c. were given, and the rabbit bled 7-10
days after the last dose. The serum was
absorbed overnight at 4°C against equal
volumes of packed cells of each of the
following types: (a) rat red blood cells,
(b) thoracic duct lymphocytes, and (c) cul-
tured syngeneic tumouir cells. The serum
was then spun for 6 h at 100,000 g to remove
immune complexes, and tested with rat or
rabbit serum as a complement source for
lysis of various cell types. No cvtotoxic
activity was detected against thoracic duct
lymphocytes, polymorphs or tumour cells.
The serum (at a dilution of 1: 100) plus
complement caused complete lysis of all
rat macrophages in a monolayer prepared
from peritoneal exudate cells.
Assay of rnonocytes by immune fluorescence
uwith RAMS.-3 x 106 blood inono-
nuclear cells were placed in siliconized
tubes, and 0 5 ml of RAMS at a final dilution
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of 1: 100 was added, and the mixture
incubated at 4°C for 1 h. The cells were
then washed twice, goat anti-rabbit serum
conjugated with fluorescein (Burroughs Well-
come) added at a dilution of 1: 10, and
incubated at 4°C for 1 h. The cells were
then washed 3 times in Medium 199, spun
down, and resuspended in 2 drops of buffered
glycerol. One drop was placed on a slide
and mounted under a coverslip. These
preparations were examined with a Leitz
u.v. microscope and positively stained cells
counted. Cells of the monocyte/macrophage
series stained positively with this preparation
of RAMS under the conditions described.
No staining was found with thoracic duct
lymph cells, cultured sarcoma cells, leukaemia
cells (i.e. the SAL myeloid rat leukaemia
or the HRL rat lymphatic leukaemia
described by Wrathmell (1976)) or cultured
normal rat einbryo fibroblasts.
Preparation of antibody-coated sheep red
cells (EA cells).-Sheep red blood cells
(SRBC) were washed 3 times and maintained
in Fischer's medium at a concentration of
4% packed volume. Rat anti-sheep red
blood cell serum was obtained by immunizino
rats i.v. 4 times with washed SRBC (2 x 108
SRBC followed 3, 6 and 13 days later by
108 SRBC; the serum was taken on Day 20).
The blood was allowed to clot, the serum
separated and heat-inactivated at 56°C
for 30 min. It was added to the SRBC
at a final dilution of 1: 100, incubated for
1 h at 37°C, after which the cells were
washed carefully to remove unbound anti-
body. The cells were then ready for the
EA rosette test.
Assay of monocytes by density separation
of rosettes formed uith EA4 cells.-Mono-
nuclear cells obtained from blood were
washed 3 times with Medium 199 to remove
traces of serum containing complement
activity. The viability of these cells was
always greater than 9500. The mononuclear
cells were made up to a concentration of
3 x 106 cells/ml, and added to an equal
volume of EA to give a final concentration
of 200 of packed red cells. These concen-
trations are quite critical, and had been
worked out in pilot experiments to achieve
a separation of B-lymphocytes from mono-
cytes. The mononuclear-EA cell mixture
was then immediately layered on to an
equal volume of Ficoll-Triosil, and spun
again as before at room temperature. Two
cell layers were formed, both were removed,
washed and examined further. The cell
pellet consisted of SRBC, together with
rosetting mononuclear cells, which could be
recovered intact and counted. Less than
2% ofthe cells in the pellet were free (i.e. un-
rosetted) viable mononuclear cells. although
some dead (i.e. trypan blue 4-ve) cells
were present. The upper layer consisted
of non-rosetted mononuclear cells.
The cells in the pellet were resuspended
in Fischer's medium and the number of
mononuclear cells present were counted.
More than 900o of these were shown (see
Results section) to be monocytes. Although
both B-lymphocytes and monocytes can
form EA rosettes, under the particular
conditions employed verv few rat B-lympho-
cytes were recovered.
RESULTS
Vcalidity ofthe procedures usedfor quantita-
tive assay of blood monocytes
The tests described in the Materials
and Methods section show that the RAMS
is specific for ma,crophages. It stained
on average 1 2 X 105 mononuclear cells/ml
of blood from normal rats and this value
corresponded closely to the number of
macrophages which could be cultured
from this volume of blood. Removal
of cells which had bound carbonyl iron
with a magnet reduced the number of
cells staining to less than one-fifth.
We conclude that carefully absorbed
RAMS recognizes a surface marker which
is present on all of the cells belonging to
the mononuclear phagocyte series except
perhaps monoblasts (i.e. promonocytes,
monocytes and macrophages).
At first sight it is surprising that the
procedure of sedimenting mononuclear
cells which have formed EA rosettes gives
rise to a preparation that contains so
few B-lymphocytes, since these also have
Fc receptors, and Parish and Hayward
(1974) found that rat B-cells appeared
as EA rosettes in the pellet of a Ficoll-
Triosil gradient. Parish and Hayward,
however, used a much higher EA: mono-
nuclear cell ratio (i.e. 10% EA as opposed
to 2 o in the procedure used by us),
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a higher Ficoll-Triosil density (1.09 as
opposed to 1-077 g/ml) higher g forces
in the separation, and an incubation
period of EA and mononuclear cells
prior to separation, while in our pro-
cedure separation begins immediately
after mixing. The two techniques were
compared using rat thoracic duct lymph
cells which contain B and T lymphocytes
but no monocytes. By the Parish and
Hayward method, 15% of the thoracic
duct cells were spun down as EA rosettes,
whereas <2% were pelleted in the
procedure used by us.
Table I summarizes the evidence that
at least 90% of the cells we obtained in
the pellet of blood mononuclear cells
were monocytes. If the cells which had
sedimented as EA rosettes were incubated
in suspension in Fisher's medium for
30 min, between 60 and 70% of them
could immediately be seen to be phago-
cytes by the presence within them of
intact red cells. This, however, under-
estimates the number of phagocytic cells,
since some of these will have digested
the red cells so that they are no longer
visible, but such cells still contain haemo-
globin, which can be visualized by appro-
priate staining, giving values of 90-95%
phagocytes.
The red cells in the pellet can be
readily removed by hypotonic lysis and
all of the mononuclear cells recovered.
On culturing for 15 min at 37°C between
50 to 70% of these cells adhered to the
bottom of plastic culture wells. How-
ever, after 241 of culture more than
90% of the cells had adhered and spread;
all of these phagocytosed EA and also
on morphological criteria were obviously
macrophages. Cells sedimented as EA
rosettes from the blood ofrats immunized
with SRBC were tested for antibody
production by the modified Jerne plaque
technique (Cunningham, 1965) but no
positive cells were observed. The RAMS
also identifies at least 90% of the cells
in the pellet as mononuclear phagocytic
cells by immunofluorescence and by caus-
ing complement-dependent lysis.
From these experiments we concluded
that the procedure described in this
paper for sedimenting EA rosettes formed
with mononuclear cells from rat blood
results in a preparation which contains
less than 5% B-cells. The evidence that
essentially all of the monocytes were
recovered is that in the upper layer
less than 1% interacted with RAMS,
adhered to glass on culture for 24 h, or
phagocytosed EA cells. In toto these
data show that the sedimentation tech-
nique described, which relies on qualita-
tive differences between EA rosettes of
B-cells and monocytes, is capable of
providing a method for enumerating the
monocytes in the blood ofrats. Whether
a similar procedure is applicable to all
other species remains to be established,
although preliminary human data is
promising.
Monocytosis associated with tumour growth
The two transplanted syngeneic sarco-
mata, HSBPA and MC-3, grow at ap-
proximately equal rates in the hind
limbs of rats following transplantation.
The monocyte count in normal rats
showed periodic variations and ranged
TABLE I.-Percentage of Monocytes among Nucleated Cells Sedimenting with Antibody-
coated Sheep Red Blood Cells (EA) as Revealed by Different Functional Tests
Assay
Immune phagocytosis (cells containing intact SRBC)
Intracellular haemoglobin staining (Benzidine)
Glass adherence (after 15 min at 37°C)
Transformation to macrophages after overnight incubation
RAMS-fluorescent staining
(RAMS + Complement)-lysis
Plaque formation by haemolysis (Jerne technique)
% Positive
cells
60-70
90
50-70
>90
90
90
0
Function
} Phagocytosis
Adherence
Binding of specific antisera
Antibody production
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FIG. Number of peripheral blood monocytes in tumour-bearing male hooded rats assayed at
intervals during tumour growth by EA rosette method. A HSBPA-tumour-bearing
rats. * MC-3-tumour-bearing rats. - A--- - - Post-excision HSBPA tumour.
---0 Post-excision MC-3 tumour. Each point represents the mean value from 5 animals,
and the vertical bars show the range for the group. The two tumours grew at approximately
equal rates, attaining average weights of 4*2 g on Day 7, 10 -4 g on Day 10, 15 g on Day 14 and
22-5g on Day 18.
from 0 5 to 1-5 x 105/ml of blood. At
the time when this experiment was
performed, the number found in the
blood of stock rats was in the lower
range of 0 5 to 1 0 x 105/ml. The figure
shows that both sarcomata induced a
progressive monocytosis but this effect
was greater with the HSBPA, in which
the number of monocytes had increased
approximately 8-fold 14 days after
transplant when the tumours weighed an
average of 15 g.
Two other tumours, HSN and MC-1,
with immunogenicities and metastatic
capacities between those of HSBPA and
MC-3 (Eccles and Alexander, 1974b),
were also tested for their effects on
monocyte levels at 10 days after inocula-
tion, and the values obtained were
0-52 x 106 -and 0-46 x 106/ml respect-
ively, which fall between the figures
obtained for HSBPA and MC-3 at this
stage of growth.
Following surgical removal of the
tumour by amputation of the leg, the
number of blood monocytes returned to
the normal range within 5 days. In
control rats, amputation of the leg did
not cause the number of monocytes to
fluctuate outside the range normally
found (i.e. 0-5-1-5 x 105/ml).
Although the EA rosette sedimenta-
tion method had been used for the
sequential analysis of blood monocytes
during tumour growth, it was felt that
the values obtained should be checked
using an entirely independent assay.
For this reason, selected blood samples
were also assayed for blood monocytes
using the fluorescent RAMS method.
The results are shown in Table II, and
it can be seen that both methods give
closely comparable results.
Infection, particularly with intracel-
lular organisms (Volkman and Collins,
1974), is known to induce moderate
monocytosis in rodents. While infection
introduced with the transplant cannot
be definitely excluded as the cause for
the monocytosis seen in the tumour-
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TABLE II.-Number of Monocytes/rnl of Blood
Rats
HSBPA-tumouir-bearing (Day 15)
MC-3-tumour-bearing (Day 16)
Normal age-matched controls
Assay method*
EA rosette formation
RAMIS-fluorescence in Ficoll-Triosil
6-3 (+0-8)x 105 7-8 (+0-3)x 105
2-4(±0-6)x105 3 (±0-4)x105
12 (±03):x 105 0-9 (±0-2)x105
* The figures given repiesent the mean values obtaine(d in groups of 5 rats with the staindard errors
following in brackets.
bearing rats, this seems improbable for
the following reasons: (1) On culture
of the tumours by the microbiological
service of the M.R.C. Laboratory Animal
Centre, no bacteria or mycoplasma could
be detected. (2) No viruses were detected
in sections examined in the electron
microscope. (3) Inoculation of cell-free
homogenates did not produce a mono-
cytosis. (4) Similar findings were made
in 3 separate experiments carried out
over a period of 12 months. In these
separate experiments the tumours were
derived from a different stock of cells it
is our practice to transplant a tumour
only 10-15 times before starting a new
series from a store of deep-frozen cells.
If infection were responsible, then the
agent can only be propagated within a
growing tumour.
DISCUSSION
Our observation that the growth of
rat sarcomata is accompanied by mono-
cytosis is in agreement with earlier
findings that transplanted tumours can
stimulate the RE system and increase
the number of granulocyte and macro-
phage precursors in bone marrow (Lappat
and Cawein, 1964; Hibberd and Metcalf,
1971; Baum and Fisher, 1972). The
experiments reported were carried out
in the hope of elucidating the reasons
for the differences in anti-inflammatory
action of different sarcomata (Eccles
and Alexander, 1974a). The magnitude
of this effect was directly correlated with
the macrophage content of the tumours
but the simple explanation that the
suppression of monocyte movement was
caused by the successful competition by
the tumour for the available monocytes
appears now to be excluded. Rats with
large HSBPA tumours have up to 8
times as many monocytes in the blood
as normal rats, but these monocytes
do not reach sites of inflammation. Yet
clearly these same monocytes gain access
to tumours and it would therefore appear
that entry of monocytes into tumours
is a different process from entry of
monocytes into sites of inflammation or
delayed hypersensitivity.
A crude estimation shows that in
rats with an HSBPA sarcoma growing
at the rate of 1 g/day, approximately
108 monocytes/day must enter the tumour,
since the percentage of macrophages
remains more or less constant. Normal
rats have a turnover rate of around
3-6 x 106 monocytes/day (Whitelaw,
1966) and therefore to supply the mono-
cytes entering the tumour, their output
has to be vastly increased. The bone
marrow is clearly capable of responding
to this demand since the rat is not
monocytopaenic but on the contrary
the number of blood monocytes is raised
by a factor of up to 8 although this
does plateau, implying an upper limit
of production. The stimulus may be
provided by a factor released from the
tumour which acts on the bone marrow
or be associated with the immune stimulus
provided by the tumour-specific antigens.
The possibility that the difference
in the degree of monocytosis induced
by the tumours studied here may be
related to the immune response of the
host appears to find support from a
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previous study (Eccles and Alexander,
1974b) in which correlations had been
observed between the biological properties
of different sarcomata and their macro-
phage content. The two tumours in-
vestigated most extensively in the present
study represent the extreme ends ofthe
spectrum. The HSBPA contains around
54% macrophages, and following surgical
excision after 14 days of growth, only
10% of the rats develop distant meta-
stases. TheMC-3 sarcomahas 8% macro-
phages, and 100% of the rats die within
6 months from distant metastases follow-
ing removal of the local sarcoma. Im-
munogenicity-defined by the number
of tumour cells which an immunized rat
is capable of rejecting-parallels the
macrophage content and is inversely
related to metastasis, i.e. rats immunized
with HSBPA are capable of rejecting
more than 107 intramuscular (i.m.)
HSBPA cells, whereas in rats immunized
with MC-3 no resistance to a subsequent
i.m. challenge could be detected (Eccles
and Alexander, 1974b). However, ab-
sense of immunogenicity as defined by
graft rejection does not necessarily imply
that there is no host reaction to antigens
on the membrane of the tumour, and
the lymphoid cells in the node draining
sarcomata of widely differing immuno-
genicities displayed comparable tumour-
specific cytotoxicity in vitro (Currie and
Alexander, 1974). The finding that the
MC-3 evokes a specific host response
and yet is not "immunogenic" has
been attributed (Alexander, 1974) to
its ability to escape destruction by cell-
mediated immunity by shedding tumour
antigens, which pre-empt the attacking
cells. If the difference in the extent
of the monocytosis produced by the
tumours has an immunological basis,
then the mechanism must be complex.
Whatever the basis of the tumour-
induced monocytosis, there remains the
puzzle as to why these monocytes fail
to enter sites of inflammation. This
also may be linked to immunity and
in particular to the presence of immune
complexes containing shedtumour-specific
antigens in the tissue fluids of tumour-
bearing rats, the existence of which
has been indicated in earlier investigations
using these sarcomata (Thomson, Eccles
and Alexander, 1973). We are testing
the hypothesis that binding of immune
complexes to the Fc receptors of mono-
cytes interferes either directly or by
steric hindrance with the membrane
recognition of sites involved in extravasa-
tion and/or chemotaxis, the processes
needed for monocytes to enter sites of
inflamnmation and hypersensitivity reac-
tions.
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